Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-08

Clinical Trial Update: Prevent Cognitive Decline in GBA-associated Parkinson's Disease [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update concerns a study aimed at preventing cognitive decline in patients with GBA-associated Parkinson's disease. The study is not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Parkinson's Disease | Phase 2 | Status: NOT_YET_RECRUITING